28 April 2010 | Researchers from the University of Queensland are recruiting patients with type-2 diabetes in central Queensland to trial a new telephone based management system.
1 April 2010 | Compliance programs in community pharmacy will be benefactors of the Rudd Government's $436 million investment to improve treatment for those with long term illnesses.
11 March 2010 | Poor efficacy and negative side effects will have a detrimental effect on the sale and development of obesity drugs, according to a forecast by Datamonitor.
9 March 2010 | A new treatment for type 2 diabetes has been approved by the Therapeutic Goods Administration.
23 February 2010 | The Australian arm of GlaxoSmithKline (GSK) has rejected claims of unethical marketing, following a US Senate report alleging the company silenced potential cardiovascular risks of its type II diabetes drug Avandia (rosiglitazone).